PinUp: Salaries of Pharma Marketers at All-Time High, Universal Flu Vaccine, More…
Welcome to the October 3, 2017, issue of Pharma Industry News Update (aka PinUp). Wow! According to an MM&M survey, salaries of pharma marketers skyrocketed in 2017. Perhaps because the drug industry needs smoke and mirrors to justify the cost of new medicines and hide the fact that some of its products - like the flu vaccines - do not work very well. Meanwhile, why has it taken so long to develop a universal flu vaccine and a searchable FDA adverse event database.
PinUp: The Various Types of Pharma “Lobbying”: Political Campaign Donations, KOLs, Patient Advocates
Welcome to the September 29, 2017, issue of Pharma Industry News Update (aka PinUp). There are various methods the drug industry uses to
PinUp: The Good, Bad, and “Hilarious” Off-Target Targeted Drug Ads on Pandora and Facebook
Welcome to the September 26, 2017, issue of Pharma Industry News Update (aka PinUp). Is the pharmaceutical industry warming up to targeted advertising? That is, serving up drug ads to people on the web and mobile devices who probably (maybe, supposedly) suffer from the specific medical condition that the drug treats. Music site Pandora is betting on it. Also betting on it are the ambulance chasers on Facebook!
PinUp: Silly Consumer Advertising, Pushing Unproven “Gamification,” Hiding Data: All in a Pharma Day’s...
Welcome to the September 22, 2017, issue of Pharma Industry News Update (aka PinUp). Pharma marketers have a difficult time thinking up 'creative' ways to sell medicines and to keep patients taking their prescriptions once sold. On the front end - i.e., DTC ads - this can lead to 'silly' ads seemingly designed to win awards rather than win the hearts and minds of consumers. On the back end - i.e., adherence - they grasp at any new 'shiny thing' such as 'gamification.' The question is, is there any proof these work?
PinUp: You Can Debate Pharma’s Digital Ad Strategy, But You Can’t Discount the Importance...
Welcome to the September 19, 2017, issue of Pharma Industry News Update (aka PinUp). While there is much debate about how much money the pharmaceutical industry spends on digital marketing, there's no debate that the industry is actively pursuing mobile solutions for improving patient care and clinical trials.
PinUp: Technology Versus TV Drug Ads, Non-Adherence, and Heart Problems
Welcome to the September 15, 2017, issue of Pharma Industry News Update (aka PinUp). Technology has saved us from actually having to view those irritating drug ads on TV, but can it solve real-world medical problems like helping us remember to take our pills and preventing deaths by early detection of heart problems?
PinUp: Fueling the opioid epidemic, Failure to report deaths due to EpiPen, Facebook clinical...
Welcome to the September 12, 2017, issue of Pharma Industry News Update (aka PinUp). Today, it's all about failures: Sales ethics failure fuels the opioid epidemic, Pfizer fails to report deaths due to EpiPen, Facebook fails to allow effective clinical trail advertising.
PinUp: A Warning Letter from FDA and a Warning Sign Regarding Digital Health Prospects
Welcome to the September 8, 2017, issue of Pharma Industry News Update (aka PinUp). FDA sent out its 2nd 'warning letter' of the year but it has nothing to do with what pharma is doing on social media. And, by the way, digital health is dead as far as one venture capitalist is concerned!
PinUp: Is point-of-care marketing of pharmaceutical products making a comeback or is it just...
Welcome to the August 29, 2017, issue of Pharma Industry News Update (aka PinUp). Is point-of-care (POC) marketing of pharmaceutical products making a comeback or is it just hype from companies desperate to gain a share of the doctor's office? My doc's office is beginning to look like a Nascar event with all the sponsored logos and posters!
PinUp: Pharma Gets Serious About Digital, But Not for Marketing
Welcome to the August 25, 2017, issue of Pharma Industry News Update (aka PinUp). It's all about digital in pharma these days, but not on the commercialization/marketing side of the business. It's full steam ahead using mobile apps in clinical trials,